Trial intelligence / Profile preview

Thalidomide and UFUR in Advanced Colorectal Cancer

NCT00890188Phase 2Unknown

Sponsor
National Cheng Kung University Hospital
Start
Jan 2009
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of thalidomide in colorectal cancer (CRC), sponsored by National Cheng Kung University Hospital. Status: unknown.

02

Drugs

thalidomide
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00890188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00890188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call